1. Home
  2. HMR vs RNTX Comparison

HMR vs RNTX Comparison

Compare HMR & RNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HMR

Heidmar Maritime Holdings Corp.

HOLD

Current Price

$1.19

Market Cap

90.3M

ML Signal

HOLD

RNTX

Rein Therapeutics Inc.

HOLD

Current Price

$0.87

Market Cap

80.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HMR
RNTX
Founded
1984
2001
Country
Greece
United States
Employees
52
10
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
90.3M
80.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
HMR
RNTX
Price
$1.19
$0.87
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
$3.00
$10.00
AVG Volume (30 Days)
384.4K
530.0K
Earning Date
06-09-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$64.04
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.73
$0.89
52 Week High
$2.10
$2.18

Technical Indicators

Market Signals
Indicator
HMR
RNTX
Relative Strength Index (RSI) 46.49 33.26
Support Level $1.11 N/A
Resistance Level $1.29 $1.33
Average True Range (ATR) 0.18 0.08
MACD -0.05 0.00
Stochastic Oscillator 5.61 1.28

Price Performance

Historical Comparison
HMR
RNTX

About HMR Heidmar Maritime Holdings Corp.

Heidmar Maritime Holdings Corp is a commercial and technical management company that operates tanker and dry-bulk vessel pools. The group, along with its subsidiaries, operates as a growing tanker pool company engaged in the commercial management and chartering of crude oil and refined petroleum product tankers. Its lines of business currently include asset management, tanker pooling, commercial and time charters, assisting clients with the buying and selling of ships, and technical management services for individual vessels, which include assistance in technical operations and crewing of the vessel. Its geographic areas are Singapore, the USA, the Marshall Islands, the United Arab Emirates, Germany, Switzerland, and Other.

About RNTX Rein Therapeutics Inc.

Rein Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing novel therapies for the treatment of orphan pulmonary and fibrosis indications with no approved or limited effective treatments. Its pipeline includes: LTI-03, a peptide, for placebo-controlled safety, tolerability, and pharmacodynamic biomarker activity trial in development for the treatment of Idiopathic Pulmonary Fibrosis, that has demonstrated the ability to protect healthy lung epithelial cells and reduce pro-fibrotic signaling; LTI-01, a proenzyme that completed a Phase 2a dose-ranging, placebo-controlled trial and a Phase 1b safety, tolerability and proof of mechanism trial in loculated pleural effusion, or LPE, patients, an indication that has no approved drug treatment.

Share on Social Networks: